Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICONA: Induction vs Consolidation Chemotherapy in Rectal Cancer
NCT05054959Phase 2Active, not recruiting
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Jun 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in rectal cancer, sponsored by Institute of Oncology Ljubljana. Started Jun 2021; status: active, not recruiting.
02
Drugs
capecitabineoxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT05054959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05054959.